Lacosamide Solution
Product Images NDC 60687-847

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 60687-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg/10 mL Lacosamide Oral Solution Cup Lid (100 mg 10 mL Lacosamide Oral Solution Cup Lid)

Lacosamide Oral Solution, USP 100 mg/10 mL bottle label from American Health Packaging. The label includes route as oral, caution for phenylketonurics containing phenylalanine 0.14 mg, volume 10 mL, and NDC 60687-847-42. It states Rx only and instructions to see package insert for full prescribing information and storage, with note for institutional use only.*

FDA Label Image

200 mg/20 mL Lacosamide Oral Solution Cup Lid (200 mg 20 mL Lacosamide Oral Solution Cup Lid)

Lacosamide Oral Solution 200 mg/20 mL bottle label by American Health Packaging. The label states the product is a prescription oral solution delivering 20 mL, contains phenylalanine (0.27 mg), and includes storage instructions not to freeze. It is labeled for institutional use with barcode and NDC 60687-847-24.*

FDA Label Image

50 mg/5 mL Lacosamide Oral Solution Cup Lid (50 mg 5 mL Lacosamide Oral Solution Cup Lid)

Lacosamide Oral Solution, USP 50 mg per 5 mL bottle label from American Health Packaging. The label includes the NDC 60687-847-40 and states it contains phenylalanine 0.07 mg. Directions and storage warnings are also noted, specifying it is for institutional use and should not be frozen.*

FDA Label Image

Lacosamide Oral Solution Usp, 10 mg/ml Label (Label)

Label for Lacosamide Oral Solution, USP 10 mg/mL by American Health Packaging. The image includes usage restrictions, pharmacist instructions, phenylketonurics information, storage temperature requirements, and a specific reference code.*

FDA Label Image

Figure 1 (Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose)

A bar graph showing median percent reduction in seizure frequency per 28 days from baseline to maintenance phase across three studies. The y-axis represents seizure reduction as median percent change from baseline, ranging from 0% to 45%. Bars compare placebo and Lacosamide doses (200 mg/day, 400 mg/day, and 600 mg/day) with statistical significance indicated for Lacosamide doses versus placebo.*

FDA Label Image

Figure 2 (Proportion of patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4)

A line graph showing the proportion of patients by responder rate for Lacosamide and placebo groups in clinical studies 2, 3, and 4. The responder rate ranges from -100% (worsening) to 100% (improvement), plotted against the percent of patients from 100% to 0%. Four lines represent placebo (N=359) and Lacosamide dosages of 200 mg/day (N=267), 400 mg/day (N=466), and 600 mg/day (N=202), illustrating comparative patient response rates across these groups.*

FDA Label Image

Figure 3 (Kalpan-Meier Analysis of Time to 2nd PGTC Seizure (Study 5) Analysis Set: Modified Full Analysis Set)

Kaplan-Meier analysis chart depicting the time to second PGTC seizure in a study comparing Lacosamide and placebo groups. The graph shows the proportion of patients remaining seizure-free over time (in days) with separate curves for 118 Lacosamide and 121 placebo patients. The chart includes risk table numbers at the bottom indicating patients at risk at various timepoints, and statistical data such as p-value, hazard ratio, and confidence intervals.*

FDA Label Image

Structural Formula (Lacosamide Str)

Chemical structure of lacosamide, depicting its molecular arrangement as typically associated with the active pharmaceutical ingredient lacosamide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.